Aomics Overview

  • Founded
  • 2015
  • Status
  • Private
  • Latest Deal Type
  • Accelerator/​Inc
  • Investors
  • 1

Aomics General Information


Developer of an anti-cancer drug. The company develops a anti-cancer drug by fusing an antibody to the paclitaxel molecule.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Drug Discovery
Primary Office
  • 2351 Faraday Avenue
  • Carlsbad, CA 92008
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Aomics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator 23-Oct-2015 Completed Startup
To view Aomics’s complete valuation and funding history, request access »

Aomics Executive Team (1)

Name Title Board Seat Contact Info
Shaochun Song Ph.D Founder & President
To view Aomics’s complete executive team members history, request access »

Aomics Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Bio, Tech and Beyond Accelerator/Incubator 000 0000 000000 0
To view Aomics’s complete investors history, request access »